Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study

BackgroundThis randomized controlled trial (RCT) aimed to compare two different routes of postoperative estrogen treatment on the improvements of menstruation, postoperative endometrial thickness, and fertility outcomes in patients with moderate to severe intrauterine adhesions (IUA).MethodsThis stu...

Full description

Bibliographic Details
Main Authors: Tianjin Yi, Xiaofang Zhang, Vani Gupta, Li Li, Qian Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1066210/full
_version_ 1811158410497884160
author Tianjin Yi
Tianjin Yi
Xiaofang Zhang
Xiaofang Zhang
Vani Gupta
Li Li
Li Li
Qian Zhong
Qian Zhong
author_facet Tianjin Yi
Tianjin Yi
Xiaofang Zhang
Xiaofang Zhang
Vani Gupta
Li Li
Li Li
Qian Zhong
Qian Zhong
author_sort Tianjin Yi
collection DOAJ
description BackgroundThis randomized controlled trial (RCT) aimed to compare two different routes of postoperative estrogen treatment on the improvements of menstruation, postoperative endometrial thickness, and fertility outcomes in patients with moderate to severe intrauterine adhesions (IUA).MethodsThis study prospectively included 78 women (age: 25 to 45 years) with moderate to severe IUA who underwent hysteroscopic resection of adhesions between March 2019 and October 2020. The enrolled patients were randomized 1:1 into either the transdermal gel group (n = 39) or the estradiol valerate oral tablet group (n = 39) on the day of receiving hysteroscopy. Postoperative endometrial thickness, AFS (American Fertility Society) score, estrogen level, and the pattern and amount of menstruation were compared. Pregnancy information was actively collected during 1-year follow-up after the operation.ResultsThe postoperative endometrium thickness was improved in both groups, and both groups gained menstruation improvement rates of 67%. For patients who underwent second-look hysteroscopy (17 from the oral group and 19 from the transdermal group), the mean AFS score declined greater than 2 in both groups. For patients with postoperative pregnancy intention, the pregnancy rates at 1-year follow-up after the procedures were 40.5% and 28% in the transdermal group and oral group, respectively. Although no statistically significant difference was observed between the two groups, patients in the transdermal group had a tendency toward increased pregnancy rate.ConclusionsTransdermal administration of estrogen is equally efficacious as oral estrogen in postoperative treatment of IUA patients with a relatively safe profile. It is very likely to broaden its indication to the field of IUA.Trial Registrationhttp://www.chictr.org.cn/showproj.aspx?proj=37197, identifier ChiCTR1900022110.
first_indexed 2024-04-10T05:23:04Z
format Article
id doaj.art-e87c0dd9a973495a84c018fc385977da
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-10T05:23:04Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-e87c0dd9a973495a84c018fc385977da2023-03-08T06:04:28ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-03-011410.3389/fendo.2023.10662101066210Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized studyTianjin Yi0Tianjin Yi1Xiaofang Zhang2Xiaofang Zhang3Vani Gupta4Li Li5Li Li6Qian Zhong7Qian Zhong8Department of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, ChinaDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, ChinaCollege of Osteopathic Medicine, New York Institute of Technology College of Osteopathic Medicine in Long Island, NY, United StatesDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, ChinaDepartment of Gynecology and Obstetrics, West China Second University Hospital of Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, ChinaBackgroundThis randomized controlled trial (RCT) aimed to compare two different routes of postoperative estrogen treatment on the improvements of menstruation, postoperative endometrial thickness, and fertility outcomes in patients with moderate to severe intrauterine adhesions (IUA).MethodsThis study prospectively included 78 women (age: 25 to 45 years) with moderate to severe IUA who underwent hysteroscopic resection of adhesions between March 2019 and October 2020. The enrolled patients were randomized 1:1 into either the transdermal gel group (n = 39) or the estradiol valerate oral tablet group (n = 39) on the day of receiving hysteroscopy. Postoperative endometrial thickness, AFS (American Fertility Society) score, estrogen level, and the pattern and amount of menstruation were compared. Pregnancy information was actively collected during 1-year follow-up after the operation.ResultsThe postoperative endometrium thickness was improved in both groups, and both groups gained menstruation improvement rates of 67%. For patients who underwent second-look hysteroscopy (17 from the oral group and 19 from the transdermal group), the mean AFS score declined greater than 2 in both groups. For patients with postoperative pregnancy intention, the pregnancy rates at 1-year follow-up after the procedures were 40.5% and 28% in the transdermal group and oral group, respectively. Although no statistically significant difference was observed between the two groups, patients in the transdermal group had a tendency toward increased pregnancy rate.ConclusionsTransdermal administration of estrogen is equally efficacious as oral estrogen in postoperative treatment of IUA patients with a relatively safe profile. It is very likely to broaden its indication to the field of IUA.Trial Registrationhttp://www.chictr.org.cn/showproj.aspx?proj=37197, identifier ChiCTR1900022110.https://www.frontiersin.org/articles/10.3389/fendo.2023.1066210/fullintrauterine adhesionestrogentransdermalmenstruationpregnancyhysteroscopy
spellingShingle Tianjin Yi
Tianjin Yi
Xiaofang Zhang
Xiaofang Zhang
Vani Gupta
Li Li
Li Li
Qian Zhong
Qian Zhong
Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
Frontiers in Endocrinology
intrauterine adhesion
estrogen
transdermal
menstruation
pregnancy
hysteroscopy
title Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
title_full Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
title_fullStr Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
title_full_unstemmed Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
title_short Transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation: A prospective randomized study
title_sort transdermal estrogen gel vs oral estrogen after hysteroscopy for intrauterine adhesion separation a prospective randomized study
topic intrauterine adhesion
estrogen
transdermal
menstruation
pregnancy
hysteroscopy
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1066210/full
work_keys_str_mv AT tianjinyi transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT tianjinyi transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT xiaofangzhang transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT xiaofangzhang transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT vanigupta transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT lili transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT lili transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT qianzhong transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy
AT qianzhong transdermalestrogengelvsoralestrogenafterhysteroscopyforintrauterineadhesionseparationaprospectiverandomizedstudy